Company · CIK 0002114044 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Hemab Therapeutics Holdings, Inc. · COAG
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 24, 2026 AForm 4 → | Sep 25, 4:45 pm EDT | Keli WalbertDirector | 36,000 | — | — | 36,000 | — |